What is Tilray Inc (TLRY) stock price today?

Tilray Inc (TLRY) currently trades at $6.24 per share. The stock has a market capitalization of $784.60M and a P/E ratio of —x.

Is TLRY stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Tilray Inc has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Tilray Inc's revenue and earnings?

Tilray Inc has trailing twelve-month (TTM) revenue of $858.27M with profit margins of -156.70%. Earnings per share (EPS) is $-14.63.

Is TLRY stock overvalued or undervalued?

Based on our DCF model, Tilray Inc's intrinsic value is $30.78, representing a margin of safety of 75.67%. The stock currently trades at a P/E of —x.

TLRY

Tilray Inc

NASDAQ: TLRY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$6.24

+1.63% today

Updated 2026-04-30

Market cap

$784.60M

P/E ratio

—

P/S ratio

0.91x

EPS (TTM)

$-14.63

Dividend yield

—

52W range

$4 – $23

Volume

4.5M

Market cap

$784.60M

P/E ratio

—

P/S ratio

0.91x

EPS (TTM)

$-14.63

Dividend yield

—

52W range

$4 – $23

Volume

4.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.7

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$10.04

+60.90%

12-Month target

—

Intrinsic (DCF)

$30.78

Margin of safety

+75.67%

0 Strong Buy2 Buy7 Hold0 Sell1 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 75.67% below intrinsic value

Risks

- Thin margins at -156.70%

- Negative free cash flow $-26.02M

- Revenue declining -7.80% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$792.12M	$844.72M	$1.07B	$1.13B	$858.27M
Net income	$-601.05M	$-1.96B	$-333.80M	$-3.00B	$-36.27M
EPS	—	—	—	—	$-14.63
Free cash flow	$-211.33M	$-12.89M	$-81.96M	$-174.98M	$-26.02M
Profit margin	-75.88%	-231.64%	-31.05%	-266.25%	-156.70%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TLRY	$784.60M	32	4.7	2.0	6.7	5.0	+75.67%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Tilray Inc trades at $6.24. Our Smart Value Score of 32/100 indicates the stock is weak. TTM revenue stands at $858.27M. with profit margins at -156.70%. Our DCF model estimates intrinsic value at $30.78.

Frequently asked questions

What is Tilray Inc's stock price?

Tilray Inc (TLRY) trades at $6.24.

Is Tilray Inc overvalued?

Smart Value Score 32/100 (Grade F, Strong Sell). DCF value $30.78.

What is the price target of Tilray Inc (TLRY)?

The analyst target price is $10.04, representing +60.9% upside from the current price of $6.24.

What is the intrinsic value of Tilray Inc (TLRY)?

Based on our DCF model, intrinsic value is $30.78, a +75.7% margin of safety versus $6.24.

What is Tilray Inc's revenue?

TTM revenue is $858.27M.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.91x

ROE-63.20%

Beta2.11

50D MA$7.00

200D MA$9.77

Shares out0.12B

Float0.44B

Short ratio—

Avg volume4.5M

Performance

1 week-11.53%

1 month-5.10%

3 months-19.42%

YTD-32.00%

1 year—

3 years—

5 years—

Compare

TLRY vs LLY →TLRY vs JNJ →TLRY vs ABBV →Stock screener →